Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1858

1.

Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.

Solomon WC, Myint W, Hou S, Kanai T, Tripathi R, Kurt Yilmaz N, Schiffer CA, Matsuo H.

Nucleic Acids Res. 2019 Aug 22;47(14):7676-7689. doi: 10.1093/nar/gkz550.

PMID:
31424549
2.

Dysphagia is associated with poor physical function in patients with acute heart failure: a prospective cohort study.

Matsuo H, Yoshimura Y, Fujita S, Maeno Y.

Aging Clin Exp Res. 2019 Jul 31. doi: 10.1007/s40520-019-01287-3. [Epub ahead of print]

PMID:
31368089
3.

Cipralphelin, a new anti-oxidative N-cinnamoyl tripeptide produced by the deep sea-derived fungal strain Penicillium brevicompactum FKJ-0123.

Matsuo H, Mokudai T, Higo M, Nonaka K, Nagano Y, Nagahama T, Niwano Y, Takahashi Y, Ōmura S, Nakashima T.

J Antibiot (Tokyo). 2019 Jul 22. doi: 10.1038/s41429-019-0208-6. [Epub ahead of print]

PMID:
31327868
4.

Algorithmic Versus Expert Human Interpretation of Instantaneous Wave-Free Ratio Coronary Pressure-Wire Pull Back Data.

Cook CM, Warisawa T, Howard JP, Keeble TR, Iglesias JF, Schampaert E, Bhindi R, Ambrosia A, Matsuo H, Nishina H, Kikuta Y, Shiono Y, Nakayama M, Doi S, Takai M, Goto S, Yakuta Y, Karube K, Akashi YJ, Clesham GJ, Kelly PA, Davies JR, Karamasis GV, Kawase Y, Robinson NM, Sharp ASP, Escaned J, Davies JE.

JACC Cardiovasc Interv. 2019 Jul 22;12(14):1315-1324. doi: 10.1016/j.jcin.2019.05.025.

5.

Psychometric evaluation of the Nurse Competence Scale: A cross-sectional study.

Juntasopeepun P, Turale S, Kawabata H, Thientong H, Uesugi Y, Matsuo H.

Nurs Health Sci. 2019 Jul 17. doi: 10.1111/nhs.12627. [Epub ahead of print]

PMID:
31317622
6.

Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

DEFINE-FLAIR Trial Investigators, Lee JM, Choi KH, Koo BK, Dehbi HM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys P, Escaned J, Davies JE.

JAMA Cardiol. 2019 Jul 17. doi: 10.1001/jamacardio.2019.2298. [Epub ahead of print]

PMID:
31314045
7.

Evaluation of Risk Factors for Major Amputation in Patients With Diabetes and Peripheral Artery Disease Receiving Antiplatelet Therapy - Post Hoc Analysis of a Prospective Observational Multicenter Cohort Study (SEASON).

Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, Naritomi H, Nakajima M, Yuki S, Awano H.

Circ J. 2019 Jul 10. doi: 10.1253/circj.CJ-19-0088. [Epub ahead of print]

8.

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.

Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, Matsuo H.

Ann Rheum Dis. 2019 Jul 8. pii: annrheumdis-2019-215521. doi: 10.1136/annrheumdis-2019-215521. [Epub ahead of print]

9.

Fusaramin, an antimitochondrial compound produced by Fusarium sp., discovered using multidrug-sensitive Saccharomyces cerevisiae.

Sakai K, Unten Y, Iwatsuki M, Matsuo H, Fukasawa W, Hirose T, Chinen T, Nonaka K, Nakashima T, Sunazuka T, Usui T, Murai M, Miyoshi H, Asami Y, Ōmura S, Shiomi K.

J Antibiot (Tokyo). 2019 Sep;72(9):645-652. doi: 10.1038/s41429-019-0197-5. Epub 2019 Jun 17.

PMID:
31204387
10.

Pragmatic Language Performance of Children Adopted Internationally.

Hwa-Froelich DA, Matsuo H.

Am J Speech Lang Pathol. 2019 May 27;28(2):501-514. doi: 10.1044/2018_AJSLP-18-0075. Epub 2019 Feb 18.

PMID:
31136229
11.

Casein kinase 1 family regulates PRR5 and TOC1 in the Arabidopsis circadian clock.

Uehara TN, Mizutani Y, Kuwata K, Hirota T, Sato A, Mizoi J, Takao S, Matsuo H, Suzuki T, Ito S, Saito AN, Nishiwaki-Ohkawa T, Yamaguchi-Shinozaki K, Yoshimura T, Kay SA, Itami K, Kinoshita T, Yamaguchi J, Nakamichi N.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11528-11536. doi: 10.1073/pnas.1903357116. Epub 2019 May 16.

12.

Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease.

Lee JM, Choi KH, Koo BK, Park J, Kim J, Hwang D, Rhee TM, Kim HY, Jung HW, Kim KJ, Yoshiaki K, Shin ES, Doh JH, Chang HJ, Cho YK, Yoon HJ, Nam CW, Hur SH, Wang J, Chen S, Kuramitsu S, Tanaka N, Matsuo H, Akasaka T.

J Am Coll Cardiol. 2019 May 21;73(19):2413-2424. doi: 10.1016/j.jacc.2019.02.060.

PMID:
31097161
13.

Effects of an anesthetic mixture of medetomidine, midazolam, and butorphanol and antagonism by atipamezole in rabbits.

Kirihara Y, Takechi M, Kurosaki K, Matsuo H, Kajitani N, Saito Y.

Exp Anim. 2019 May 14. doi: 10.1538/expanim.18-0183. [Epub ahead of print]

14.

Case of ultraviolet B-mediated photosensitivity during the administration of voriconazole.

Mizuno S, Itoh M, Matsuo H, Kikuchi S, Asahina A.

J Dermatol. 2019 Apr 25. doi: 10.1111/1346-8138.14874. [Epub ahead of print] No abstract available.

PMID:
31021004
15.

1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry.

Patel MR, Nørgaard BL, Fairbairn TA, Nieman K, Akasaka T, Berman DS, Raff GL, Hurwitz Koweek LM, Pontone G, Kawasaki T, Sand NPR, Jensen JM, Amano T, Poon M, Øvrehus KA, Sonck J, Rabbat MG, Mullen S, De Bruyne B, Rogers C, Matsuo H, Bax JJ, Leipsic J.

JACC Cardiovasc Imaging. 2019 Mar 17. pii: S1936-878X(19)30227-X. doi: 10.1016/j.jcmg.2019.03.003. [Epub ahead of print]

16.

Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort.

Toyoda Y, Mančíková A, Krylov V, Morimoto K, Pavelcová K, Bohatá J, Pavelka K, Pavlíková M, Suzuki H, Matsuo H, Takada T, Stiburkova B.

Cells. 2019 Apr 18;8(4). pii: E363. doi: 10.3390/cells8040363.

17.

Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry.

Shiono Y, Matsuo H, Kawasaki T, Amano T, Kitabata H, Kubo T, Morino Y, Yoda S, Sakamoto T, Ito H, Shite J, Otake H, Tanaka N, Terashima M, Kadota K, Patel MR, Nieman K, Rogers C, Nørgaard BL, Bax JJ, Raff GL, Chinnaiyan KM, Berman DS, Fairbairn TA, Hurwitz Koweek LM, Leipsic J, Akasaka T.

Circ J. 2019 May 24;83(6):1293-1301. doi: 10.1253/circj.CJ-18-1269. Epub 2019 Apr 18.

18.

Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.

Commun Biol. 2019 Apr 8;2:115. doi: 10.1038/s42003-019-0339-0. eCollection 2019.

19.

Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis.

Westra J, Tu S, Campo G, Qiao S, Matsuo H, Qu X, Koltowski L, Chang Y, Liu T, Yang J, Andersen BK, Eftekhari A, Christiansen EH, Escaned J, Wijns W, Xu B, Holm NR.

Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28283. [Epub ahead of print]

PMID:
30963676
20.

Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio.

Jerabek S, Zemanek D, Pudil J, Bayerova K, Kral A, Kopriva K, Kawase Y, Omori H, Tanigaki T, Chen Z, Vodzinska A, Branny M, Matsuo H, Mates M, Sonka M, Kovarnik T.

Acta Cardiol. 2019 Apr 4:1-6. doi: 10.1080/00015385.2019.1586089. [Epub ahead of print]

PMID:
30945607
21.

[Comparison of Pegfilgrastim and Filgrastim for the Primary Prophylactic Effect for Preventing Febrile Neutropenia in Patients Undergoing Rituximab with Dose-adjusted EPOCH Chemotherapy].

Kataoka T, Sakurashita H, Taogoshi T, Nishigakiuchi R, Murase T, Izumitani S, Saeki Y, Matsuo H.

Yakugaku Zasshi. 2019;139(4):629-633. doi: 10.1248/yakushi.18-00101. Japanese.

22.

A randomized, controlled, phase II clinical trial of β-D-mannuronic acid (M2000) in pre-surgical breast cancer patients at early stage (T1-T2).

Kashefi S, Omranipour R, Mahmoodzadeh H, Ahmadi H, Alikhassi A, Hosseini M, Cuzzocrea S, Rehm BHA, Matsuo H, Mirshafiey A.

Clin Exp Pharmacol Physiol. 2019 Jun;46(6):527-532. doi: 10.1111/1440-1681.13086.

PMID:
30887570
23.

Ferroelectrics with a controlled oxygen-vacancy distribution by design.

Noguchi Y, Matsuo H, Kitanaka Y, Miyayama M.

Sci Rep. 2019 Mar 12;9(1):4225. doi: 10.1038/s41598-019-40717-0.

24.

Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease.

Omori H, Witberg G, Kawase Y, Tanigaki T, Okamoto S, Hirata T, Sobue Y, Ota H, Kamiya H, Okubo M, Valzer O, Kornowski R, Matsuo H.

Int J Cardiol. 2019 May 15;283:17-22. doi: 10.1016/j.ijcard.2019.01.072. Epub 2019 Jan 27.

PMID:
30819589
25.

Influence of Sex on Relationship Between Total Anatomical and Physiologic Disease Burdens and Their Prognostic Implications in Patients With Coronary Artery Disease.

Kim CH, Koo BK, Lee JM, Shin ES, Park J, Choi KH, Hwang D, Rhee TM, Zhang J, Choi YJ, Lee SY, Choi JH, Doh JH, Nam CW, Wang J, Chen S, Kuramitsu S, Tanaka N, Matsuo H, Akasaka T.

J Am Heart Assoc. 2019 Mar 5;8(5):e011002. doi: 10.1161/JAHA.118.011002.

26.

Post-occlusional hyperemia for fractional flow reserve assessment and pull-back curve analysis.

Hirata T, Tanigaki T, Kawase Y, Hirakawa A, Omori H, Okamoto S, Ota H, Sobue Y, Kikuchi J, Okubo M, Kamiya H, Kawasaki M, Suzuki T, Pijls NHJ, Matsuo H.

Cardiovasc Interv Ther. 2019 Feb 20. doi: 10.1007/s12928-019-00579-9. [Epub ahead of print]

PMID:
30788697
27.

[A CASE OF FOOD-DEPENDENT EXERCISE-INDUCED ANAPHYLAXIS BY SHRIMP: FRUCTOSE 1, 6- BISPHOSPHATE ALDOLASE IS SUPPOSED AS CAUSATIVE COMPONENT DESPITE NEGATIVE ALLERGEN-SPECIFIC IGE TEST (IMMUNOCAP®)].

Tonomura K, Fujimoto R, Okuda Y, Iba N, Sakamoto S, Kosugi E, Kishida H, Matsuo H, Kataoka Y.

Arerugi. 2019;68(1):48-53. doi: 10.15036/arerugi.68.48. Japanese.

PMID:
30787243
28.

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N.

Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Review.

29.

Abnormal Fractional Flow Reserve in Nonobstructive Coronary Artery Disease.

Imai S, Kondo T, Stone GW, Kawase Y, Ahmadi AA, Narula J, Matsuo H.

Circ Cardiovasc Interv. 2019 Feb;12(2):e006961. doi: 10.1161/CIRCINTERVENTIONS.118.006961.

PMID:
30767658
30.

Sternal Fracture Complicated by a Subcutaneous Abscess in a 5-Year-Old Boy and Diagnosed Using Point-of-Care Ultrasound.

Fukuhara S, Sameshima T, Matsuo H, Ohashi T.

J Emerg Med. 2019 May;56(5):536-539. doi: 10.1016/j.jemermed.2018.12.040. Epub 2019 Feb 10.

PMID:
30745197
31.

Feasibility and safety of jailed-pressure wire technique using durable optical fiber pressure wire for intervention of coronary bifurcation lesions.

Omori H, Kawase Y, Hara M, Tanigaki T, Okamoto S, Hirata T, Kikuchi J, Ota H, Sobue Y, Miyake T, Kawamura I, Okubo M, Kamiya H, Tsuchiya K, Suzuki T, Pijls NHJ, Matsuo H.

Catheter Cardiovasc Interv. 2019 Aug 1;94(2):E61-E66. doi: 10.1002/ccd.28106. Epub 2019 Feb 5.

PMID:
30723996
32.

Development of a liquid chromatography-tandem mass spectrometry method for quantification of the egg allergen ovalbumin in rat plasma.

Ogino R, Yokooji T, Omoto A, Taogoshi T, Morita E, Matsuo H.

Allergol Int. 2019 Jul;68(3):372-374. doi: 10.1016/j.alit.2018.12.005. Epub 2019 Jan 31. No abstract available.

33.

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment.

Sen S, Ahmad Y, Dehbi HM, Howard JP, Iglesias JF, Al-Lamee R, Petraco R, Nijjer S, Bhindi R, Lehman S, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Silva PC, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J, Davies JE.

J Am Coll Cardiol. 2019 Feb 5;73(4):444-453. doi: 10.1016/j.jacc.2018.10.070.

34.

Effects of three gait retraining techniques in runners with patellofemoral pain.

Dos Santos AF, Nakagawa TH, Lessi GC, Luz BC, Matsuo HTM, Nakashima GY, Maciel CD, Serrão FV.

Phys Ther Sport. 2019 Mar;36:92-100. doi: 10.1016/j.ptsp.2019.01.006. Epub 2019 Jan 18.

PMID:
30703643
35.

Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects.

Okimoto S, Kuroda S, Tashiro H, Kobayashi T, Taogoshi T, Matsuo H, Ohdan H.

Hepatol Res. 2019 Jun;49(6):663-675. doi: 10.1111/hepr.13317. Epub 2019 Feb 15.

PMID:
30675748
36.

Effects of the Prdx2 depletion on blood pressure and life span in spontaneously hypertensive rats.

Mahal Z, Fujikawa K, Matsuo H, Zahid HM, Koike M, Misumi M, Kaneko T, Mashimo T, Ohara H, Nabika T.

Hypertens Res. 2019 May;42(5):610-617. doi: 10.1038/s41440-019-0207-9. Epub 2019 Jan 17.

PMID:
30655626
37.

Safety of 90Y-ibritumomab Tiuxetan Treatment for Japanese Patients in Real-world Clinical Practice.

Yoshikawa H, Sakurashita H, Izumitani S, Taogoshi T, Saeki Y, Matsuo H.

Yakugaku Zasshi. 2019;139(1):131-134. doi: 10.1248/yakushi.18-00112.

38.

International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.

Rezaieyazdi Z, Farooqi A, Soleymani-Salehabadi H, Ahmadzadeh A, Aslani M, Omidian S, Sadoughi A, Vahidi Z, Khodashahi M, Zamurrad S, Mortazavi-Jahromi SS, Fallahzadeh H, Hosseini M, Aghazadeh Z, Ekhtiari P, Matsuo H, Rehm BHA, Cuzzocrea S, D'Aniello A, Mirshafiey A.

Inflammopharmacology. 2019 Jan 2. doi: 10.1007/s10787-018-00557-2. [Epub ahead of print]

PMID:
30604197
39.

Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics.

Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, Kozuma K, Nakamura M, Yokoi H, Kobayashi Y, Ikari Y.

Cardiovasc Interv Ther. 2019 Jan;34(1):85-96. doi: 10.1007/s12928-018-0559-0. Epub 2018 Dec 27. Review.

PMID:
30588572
40.

Influence of Target Vessel on Prognostic Relevance of Fractional Flow Reserve After Coronary Stenting.

Hwang D, Lee JM, Lee HJ, Kim SH, Nam CW, Hahn JY, Shin ES, Matsuo A, Tanaka N, Matsuo H, Lee SY, Doh JH, Koo BK.

EuroIntervention. 2018 Dec 18. pii: EIJ-D-18-00913. doi: 10.4244/EIJ-D-18-00913. [Epub ahead of print]

41.

Intestinal absorption of the wheat allergen gliadin in rats.

Yokooji T, Fukushima T, Hamura K, Ninomiya N, Ohashi R, Taogoshi T, Matsuo H.

Allergol Int. 2019 Apr;68(2):247-253. doi: 10.1016/j.alit.2018.11.005. Epub 2018 Dec 15.

42.

New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by Streptomyces sp. AM-2504.

Kimura T, Suga T, Kameoka M, Ueno M, Inahashi Y, Matsuo H, Iwatsuki M, Shigemura K, Shiomi K, Takahashi Y, Ōmura S, Nakashima T.

J Antibiot (Tokyo). 2019 Mar;72(3):169-173. doi: 10.1038/s41429-018-0117-0. Epub 2018 Dec 10.

PMID:
30532036
43.

Nanaomycin I and J: New nanaomycins generated by mycothiol-mediated compounds from "Streptomyces rosa subsp. notoensis" OS-3966.

Matsuo H, Noguchi Y, Také A, Nakanishi J, Shigemura K, Sunazuka T, Takahashi Y, Ōmura S, Nakashima T.

J Biosci Bioeng. 2019 May;127(5):549-553. doi: 10.1016/j.jbiosc.2018.10.013. Epub 2018 Nov 29.

PMID:
30503170
44.

Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational Study.

Miyata T, Higashi Y, Shigematsu H, Origasa H, Fujita M, Matsuo H, Naritomi H, Matsuda H, Nakajima M, Yuki S, Awano H.

Angiology. 2019 Jul;70(6):506-514. doi: 10.1177/0003319718814351. Epub 2018 Nov 26.

PMID:
30477334
45.

Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.

Hou S, Silvas TV, Leidner F, Nalivaika EA, Matsuo H, Kurt Yilmaz N, Schiffer CA.

J Chem Theory Comput. 2019 Jan 8;15(1):637-647. doi: 10.1021/acs.jctc.8b00545. Epub 2018 Dec 11.

46.

Risk factors increasing blood pressure in Japanese colorectal cancer patients treated with bevacizumab.

Nishihara M, Morikawa N, Yokoyama S, Nishikura K, Yasuhara M, Matsuo H.

Pharmazie. 2018 Nov 1;73(11):671-675. doi: 10.1691/ph.2018.8664.

PMID:
30396388
47.

An Application of Photoactivatable Substrate for the Evaluation of Epithelial-mesenchymal Transition Inhibitors.

Nakanishi J, Sugiyama K, Matsuo H, Takahashi Y, Omura S, Nakashima T.

Anal Sci. 2019 Jan 10;35(1):65-69. doi: 10.2116/analsci.18SDP07. Epub 2018 Nov 2.

48.

Effects of Osthol Isolated from Cnidium monnieri Fruit on Urate Transporter 1.

Tashiro Y, Sakai R, Hirose-Sugiura T, Kato Y, Matsuo H, Takada T, Suzuki H, Makino T.

Molecules. 2018 Nov 1;23(11). pii: E2837. doi: 10.3390/molecules23112837.

49.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

50.

Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.

Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y, Yamakawa M, Nakahara K, Takamatsu K, Matsuo H, Ando Y.

Expert Rev Neurother. 2018 Dec;18(12):953-965. doi: 10.1080/14737175.2018.1540304. Epub 2018 Nov 1.

PMID:
30352532

Supplemental Content

Loading ...
Support Center